Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VGT-309 for Intraoperative Imaging in Lung Cancer Surgery
NCT05400226Phase 2Completed
- Sponsor
- Vergent Bioscience
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abenacianine in lung cancer, sponsored by Vergent Bioscience. Started May 2022; status: completed.
02
Drugs
abenacianine
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT05400226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05400226.